#$%^&*AU2020230219A120201001.pdf#####ABSTRACT A combination when used to treat a cancer expressing a tumor antigen, comprising: (i) an antibody or functional fragment thereof that is tumor antigen specific; and (ii) an agonist of TLR7 or TLR8 or both, wherein the antibody or functional fragment thereof of (i) and the agonist of (ii) are not linked to each other.1/10 A. 400S300200- 100TLRL pg/mL Figure 1 A. B 100008000c 6000400020000- T --- r TLRL pg/mL Figure 1 B